Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 727

1.

The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.

Pfau PR, Perlman SB, Stanko P, Frick TJ, Gopal DV, Said A, Zhang Z, Weigel T.

Gastrointest Endosc. 2007 Mar;65(3):377-84.

PMID:
17321235
2.

Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.

Sandha GS, Severin D, Postema E, McEwan A, Stewart K.

Gastrointest Endosc. 2008 Mar;67(3):402-9. doi: 10.1016/j.gie.2007.09.006.

PMID:
18178202
4.

Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.

McDonough PB, Jones DR, Shen KR, Northup PG, Galysh RL, Hernandez A, White GE, Kahaleh M, Shami VM.

Am J Gastroenterol. 2008 Mar;103(3):570-4. Epub 2007 Oct 17.

PMID:
17941963
5.

Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer.

Choi J, Kim SG, Kim JS, Jung HC, Song IS.

Surg Endosc. 2010 Jun;24(6):1380-6. doi: 10.1007/s00464-009-0783-x. Epub 2009 Dec 24.

PMID:
20033712
6.

Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.

Räsänen JV, Sihvo EI, Knuuti MJ, Minn HR, Luostarinen ME, Laippala P, Viljanen T, Salo JA.

Ann Surg Oncol. 2003 Oct;10(8):954-60.

PMID:
14527917
7.

Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.

Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ.

Cancer. 2007 Jan 1;109(1):125-34.

8.

Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.

Omloo JM, Sloof GW, Boellaard R, Hoekstra OS, Jager PL, van Dullemen HM, Fockens P, Plukker JT, van Lanschot JJ.

Endoscopy. 2008 Jun;40(6):464-71. doi: 10.1055/s-2008-1077302.

PMID:
18543134
9.

The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.

Flamen P, Lerut A, Van Cutsem E, Cambier JP, Maes A, De Wever W, Peeters M, De Leyn P, Van Raemdonck D, Mortelmans L.

J Thorac Cardiovasc Surg. 2000 Dec;120(6):1085-92.

10.

Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.

Malone JP, Gerberi MA, Vasireddy S, Hughes LF, Rao K, Shevlin B, Kuhn M, Collette D, Tennenhouse J, Robbins KT.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1119-25. doi: 10.1001/archoto.2009.152.

PMID:
19917925
11.

Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer.

Chang KJ, Soetikno RM, Bastas D, Tu C, Nguyen PT.

Endoscopy. 2003 Nov;35(11):962-6.

PMID:
14606021
12.

The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus.

Pech O, May A, Günter E, Gossner L, Ell C.

Am J Gastroenterol. 2006 Oct;101(10):2223-9.

PMID:
17032186
13.

The early use of PET-CT alters the management of patients with esophageal cancer.

Williams RN, Ubhi SS, Sutton CD, Thomas AL, Entwisle JJ, Bowrey DJ.

J Gastrointest Surg. 2009 May;13(5):868-73. doi: 10.1007/s11605-009-0812-z. Epub 2009 Jan 28.

PMID:
19184245
14.
15.

EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.

Mertz HR, Sechopoulos P, Delbeke D, Leach SD.

Gastrointest Endosc. 2000 Sep;52(3):367-71.

PMID:
10968852
16.

Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach?

Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T.

World J Surg. 2003 Oct;27(10):1105-12. Epub 2003 Aug 18.

PMID:
12917769
17.

Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.

Sloof GW.

Best Pract Res Clin Gastroenterol. 2006;20(5):941-57. Review.

PMID:
16997171
18.

Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.

Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH 3rd, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA.

J Nucl Med. 2009 Aug;50(8):1205-13. doi: 10.2967/jnumed.109.062075. Epub 2009 Jul 17.

19.
20.

Supplemental Content

Support Center